Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
First-in-Human Study of PA-001 in Healthy Japanese Male Subjects
jRCTs031210601Phase 1Completed
- Sponsor
- Applicable
- Start
- Feb 2022
- Modality
- Cyclic Peptides → Modified Peptides → Peptides
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of PA-001 in coronavirus disease 2019 (COVID-19), sponsored by Applicable. Started Feb 2022; status: completed.
02
Drugs
PA-001
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on jRCTs031210601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031210601.